Got US$100? Here are two stocks to explore

3 min read | July 22, 2021 12:45 PM PDT | By Team Kalkine Media

Summary

  • R. Horton, Inc. (NYSE:DHI) reported total revenue of US$7.2 billion in Q3, 2021.
  • CVS Health Corporation’s (NYSE:CVS) revenue increased to US$69.3 billion in Q1, 2021, up 3.5 percent YoY.
  • DHI’s stock price increased by 29.06 percent YTD.

Investment in the stock market may sound like a business of the wealthy. But aspirants, even with a minimum of US$100, can invest.

In many sectors like housing, oil and gas, and aviation, the pandemic has been a significant disruptor as the prices of products and services wavered due to the recession caused by covid. But now, the economies are getting better, and so are the companies.

Here we explore two stocks for those who can afford US$100.

Source: Pixabay.

Also read: NVIDIA soars 3% day after it starts trading split-adjusted stocks

D.R. Horton, Inc. (NYSE:DHI)

D.R. Horton, Inc, a homebuilding company, builds and sells different types of homes, like detached and attached duplexes, across 29 states in the USA.

DHI’s stock traded at US$89.05 at 11.25 am ET, down by 2.59 percent over the previous closing price. Its stock price increased by 29.06 percent YTD. DHI has a market capitalization of US$32.1 billion.

The P/E ratio is 10.34, while the forward P/E one year is 8.74. Earnings per share and annual dividend are US$8.63 and US$0.80, respectively. The current yield is 0.9 percent, and the beta is 1.65.

The company’s highest stock price in the last 52 weeks was US$106.89, and the lowest was US$62.26. The share volume is 2,796,681.

DHI reported total revenue of US$7.2 billion in Q3, 2021, compared to US$5.3 billion in Q3 of 2020. Gross profit for this period was US$2 billion compared to US$1.3 billion in Q3 of 2020. Operating income in Q3, 2021, was US$1.4 billion compared to US$782.4 million in Q3, 2020.

CVS Health Corporation (NYSE:CVS)


CVS Health Corporation, a healthcare company, operates pharmacy retail stores and delivers medicines through online orders.

CVS's stock traded at US$82.12 at 11.56 am ET, down 0.53 percent over the previous closing price. Its stock price increased by 20.32 percent YTD. CVS has a market capitalization of US$108 billion.

The P/E ratio is 14.62. Earnings per share and annual dividend are US$5.61 and US$2, respectively. The current yield is 2.41 percent, and the beta is 0.80.

The company’s highest stock price for the last 52 weeks was US$90.61, and the lowest was US$55.36. The share volume is 1,383,901.

Also read:  Looking for growth stocks? Here are two options

Total revenue of CVS increased to US$69.3 billion in Q1, 2021, up by 3.5 percent YoY. Diluted EPS for the quarter was US$1.68, a 9.8 percent increase YoY. The company generated a cash flow of US$2.9 billion from operations. Its gross profit for Q1, 2021, was US$28 billion, and in Q1, 2020, it was US$26 billion. In addition, CVS recorded an operating income of US$3.5 billion, up by US$119 million YoY.

Please note: The above constitutes a preliminary view and any interest in stocks/cryptocurrencies should be evaluated further from an investment point of view.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.